What should investors do with Dr Reddy’s Laboratories post Q2 results; Buy, sell or hold?

Dr Reddys Laboratories share price rose 1 percent in early trade on November 1 as the company announced its second quarter earnings.
Pharma major Dr Reddys Laboratories on October 29 reported a consolidated profit after tax (PAT) of Rs 992 crore for the…

Click here to view the original article.